Cargando…

Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis

Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by the progressive destruction of small- and medium-sized intrahepatic bile ducts with resultant cholestasis and progressive fibrosis. Ursodeoxycholic acid and obethicholic acid are the only agents appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arsenijevic, Aleksandar, Harrell, C. Randall, Fellabaum, Crissy, Volarevic, Vladislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749170/ https://www.ncbi.nlm.nih.gov/pubmed/29410945 http://dx.doi.org/10.1155/2017/7492836

Ejemplares similares

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma
por: Harrell, C. Randall, et al.
Publicado: (2019)

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Molecular mechanisms underlying therapeutic potential of pericytes
por: Harrell, C. Randall, et al.
Publicado: (2018)

Stem Cells Therapy for Spinal Cord Injury
por: Gazdic, Marina, et al.
Publicado: (2018)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
por: Harrell, C. Randall, et al.
Publicado: (2019)

Risks of Using Sterilization by Gamma Radiation: The Other Side of the Coin
por: Harrell, C. Randall, et al.
Publicado: (2018)

Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2019)

Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure
por: Harrell, Carl Randall, et al.
Publicado: (2022)

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs
por: Volarevic, Vladislav, et al.
Publicado: (2019)

The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration
por: Miloradovic, Dragana, et al.
Publicado: (2020)

Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development
por: Arsenijevic, Aleksandar, et al.
Publicado: (2020)

NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2023)

Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
por: Harrell, Carl Randall, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases
por: Gazdic, Marina, et al.
Publicado: (2017)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
por: Harrell, Carl Randall, et al.
Publicado: (2020)

The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2021)

Stem Cells as New Agents for the Treatment of Infertility: Current and Future Perspectives and Challenges
por: Volarevic, Vladislav, et al.
Publicado: (2014)

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
por: Volarevic, Vladislav, et al.
Publicado: (2011)

Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Modulation of Obstructive Sleep Apnea
por: Zdravkovic, Marija, et al.
Publicado: (2023)

Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives
por: Yang, Yanlei, et al.
Publicado: (2022)

Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis
por: Floreani, Annarosa
Publicado: (2020)

Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
por: Simovic Markovic, Bojana, et al.
Publicado: (2017)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

New treatments/targets for primary biliary cholangitis
por: Corpechot, Christophe, et al.
Publicado: (2019)

Stem Cells and Labeling for Spinal Cord Injury
por: Gazdic, Marina, et al.
Publicado: (2016)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis
por: Medford, Abigail, et al.
Publicado: (2023)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2mntu5ud58j579onekge35o23l